GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued ...

Allosteric mechanisms enable proteins to transmit regulatory signals between spatially distinct sites, thereby modulating activity, specificity and interaction networks. Rather than invoking ...

GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued to reposition dipraglurant mGlu5 NAM for brain injury re ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that its Phase 3 ...

Jamie A. Abbott, PhD, a research scientist and research assistant professor in the Department of Biochemistry in the Jacobs School of Medicine and Biomedical Sciences, has received a Young ...

PRESCOTT, AZ, UNITED STATES, May 20, 2026 /EINPresswire.com/ -- Sweetener science just got a lot more interesting.

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

STOCKHOLM, SE / ACCESS Newswire / May 19, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on ...

Bank of America Global Healthcare Conference 2026 May 12, 2026 8:01 PM EDTCompany ParticipantsJeffrey Finer - Co-Founder, CEO ...

GRIN Therapeutics' Pivotal Phase 3 Beeline Study Initiated In Europe. European initiation advances global registrational program for investigational radiprodil in GRIN-NDD; initiation augments sites ...

Assembly Biosciences (NASDAQ:ASMB) Chief Medical Officer Anuj Gaggar outlined the company's virology strategy and upcoming clinical priorities during a Bank of America-hosted discussion, emphasizing ...